Otcenásek M
Biofarmaceutický výzkumný ústav, spolecné pracovistĕ Ustavu experimentální biofarmacie AVCR a a.s. PRO.MED.CS Hradec Králové.
Cesk Epidemiol Mikrobiol Imunol. 1993 Jun;42(2):80-2.
The author gives an account of a report of the Nomenclature Committee of the International Society for Human and Animal Mycology making the present terminology of mycoses more precise and unified. Changes recommended by the Committee are designed to eliminate the instability of currently used terms influenced by new names of mycological taxonomy as well as by clinical aspects and the pathology of mycoses. The essential feature of the changes is a recommendation for fungal disease names not based on the word derived from the taxon of the causative fungal genus but providing, in a narrow or broader way, information on the clinical and pathological entity caused by the fungus. The individual recommendations are supplemented by explanatory examples and a list of accepted and rejected fungal disease names is tabulated.
作者介绍了国际人类和动物真菌学会命名委员会的一份报告，该报告使目前的真菌病术语更加精确和统一。委员会建议的更改旨在消除当前使用的术语因真菌分类学新名称以及真菌病的临床方面和病理学而产生的不稳定性。这些更改的基本特征是建议真菌病名称不应基于致病真菌属分类单元衍生的词，而是以狭义或广义的方式提供由真菌引起的临床和病理实体的信息。个别建议辅以解释性示例，并列出了已接受和被拒绝的真菌病名称表格。
